Literature DB >> 1458946

Evaluation of the consistency of Acute Physiology and Chronic Health Evaluation (APACHE II) scoring in a surgical intensive care unit.

M M Berger1, A Marazzi, J Freeman, R Chioléro.   

Abstract

OBJECTIVES: To determine the applicability of the Acute Physiology and Chronic Health Evaluation (APACHE II) scoring system in a Swiss ICU, and to evaluate its utility in evaluating data from 2 yrs of consecutive admissions to show that the predictability of outcome is similar to that predictability observed by Knaus et al. in 1985 (in 5,815 patients), with the provision that large numbers of patients are studied.
DESIGN: Prospective clinical trial over 2 yrs, with statistical analysis of the Swiss patients, and between the Swiss patients and the patients studied by Knaus et al. Receiver operating characteristic curves were calculated.
SETTING: Surgical ICU in a Swiss university hospital. PATIENTS: A total of 2,061 consecutive patients admitted to the surgical ICU who were classified as postoperative (elective or emergency) and nonoperative. Hospital mortality rate was considered.
RESULTS: Patients were 53 +/- 16 yrs of age. Mean APACHE II score was 10.5 +/- 7.0. The mean APACHE II score was significantly (p < .001) lower in the 1,813 survivors (9.0 +/- 5.2) than in the 248 nonsurvivors (21.5 +/- 8.5). The mortality rate was higher among the Swiss patients when compared with the patients studied by Knaus et al. who had postoperative scores of 20 to 29 and nonoperative scores of > 24. The distribution of the scores and mortality rates were stable during the two study periods, as were the differences in mortality rates between the Swiss population and that population studied by Knaus et al. Sensitivity and specificity of the scores were highest in the emergency surgery group (87% and 78%), and lowest in the elective surgery group (76% and 73%). The APACHE equation underestimated the risk of death.
CONCLUSIONS: The APACHE II score, because of its consistency over time and the stability of the mortality rates, can be used in our surgical ICU without modification. The calculated risk of death gives no additional information.

Entities:  

Mesh:

Year:  1992        PMID: 1458946     DOI: 10.1097/00003246-199212000-00014

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Accuracy and efficiency of an automated system for calculating APACHE II scores in an intensive care unit.

Authors:  V J Gooder; B R Farr; M P Young
Journal:  Proc AMIA Annu Fall Symp       Date:  1997

2.  Severe Thrombocytopenia Caused by Vancomycin in the Intensive Care Unit: A Case Report.

Authors:  Xiao-Xiao Li; Guan-Ru Wang; Chao Li; Na He; Peng Yao; Yin-Chu Cheng; Chu-Hui Wang; Qing-Gang Ge; Min Yi; Zong-Yu Wang; Lu-Wen Shi; Rong-Sheng Zhao
Journal:  Front Med (Lausanne)       Date:  2022-06-09

3.  Relaparotomies: Why is Mortality Higher?

Authors:  Ercan Gedik; Kazým Söylemez; Sadullah Girgin; Ersin Uysal; Ýbrahim Taçyýldýz
Journal:  Eur J Trauma Emerg Surg       Date:  2009-05-12       Impact factor: 3.693

4.  The Ability of the Acute Physiology and Chronic Health Evaluation (APACHE) IV Score to Predict Mortality in a Single Tertiary Hospital.

Authors:  Jae Woo Choi; Young Sun Park; Young Seok Lee; Yeon Hee Park; Chaeuk Chung; Dong Il Park; In Sun Kwon; Ju Sang Lee; Na Eun Min; Jeong Eun Park; Sang Hoon Yoo; Gyu Rak Chon; Young Hoon Sul; Jae Young Moon
Journal:  Korean J Crit Care Med       Date:  2017-08-31

5.  Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis.

Authors:  Suzana Bojic; Jelena Kotur-Stevuljevic; Nevena Kalezic; Zorana Jelic-Ivanovic; Aleksandra Stefanovic; Ivan Palibrk; Lidija Memon; Zdravko Kalaba; Marina Stojanovic; Sanja Simic-Ogrizovic
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

6.  Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery.

Authors:  Suzana Bojic; Jelena Kotur-Stevuljevic; Aleksandra Aleksic; Jasna Gacic; Lidija Memon; Sanja Simic-Ogrizovic
Journal:  Dis Markers       Date:  2018-05-16       Impact factor: 3.434

7.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.